BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19690183)

  • 1. The 6q22.33 locus and breast cancer susceptibility.
    Kirchhoff T; Chen ZQ; Gold B; Pal P; Gaudet MM; Kosarin K; Levine DA; Gregersen P; Spencer S; Harlan M; Robson M; Klein RJ; Hudis CA; Norton L; Dean M; Offit K
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2468-75. PubMed ID: 19690183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
    Ghoussaini M; French JD; Michailidou K; Nord S; Beesley J; Canisus S; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Dennis J; Bolla MK; Wang Q; Dicks E; Milne RL; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Alonso MR; Pita G; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Tessier DC; Vincent D; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; Wu AH; Van Den Berg D; Lambrechts D; Floris G; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Hallberg E; Giles GG; Haiman CA; Le Marchand L; Goldberg MS; Teo SH; Yip CH; Borresen-Dale AL; ; Zheng W; Cai Q; Winqvist R; Pylkäs K; Andrulis IL; Devilee P; Tollenaar RA; García-Closas M; Figueroa J; Hall P; Czene K; Brand JS; Darabi H; Eriksson M; Hooning MJ; Koppert LB; Li J; Shu XO; Zheng Y; Cox A; Cross SS; Shah M; Rhenius V; Choi JY; Kang D; Hartman M; Chia KS; Kabisch M; Torres D; Luccarini C; Conroy DM; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Olswold C; Slager S; Shen CY; Hou MF; Swerdlow A; Schoemaker MJ; Simard J; Pharoah PD; Kristensen V; Chenevix-Trench G; Easton DF; Dunning AM; Edwards SL
    Am J Hum Genet; 2016 Oct; 99(4):903-911. PubMed ID: 27640304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
    Glubb DM; Maranian MJ; Michailidou K; Pooley KA; Meyer KB; Kar S; Carlebur S; O'Reilly M; Betts JA; Hillman KM; Kaufmann S; Beesley J; Canisius S; Hopper JL; Southey MC; Tsimiklis H; Apicella C; Schmidt MK; Broeks A; Hogervorst FB; van der Schoot CE; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Ruebner M; Ekici AB; Beckmann MW; Peto J; dos-Santos-Silva I; Fletcher O; Johnson N; Pharoah PD; Bolla MK; Wang Q; Dennis J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Burwinkel B; Marme F; Yang R; Surowy H; Guénel P; Truong T; Menegaux F; Sanchez M; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; González-Neira A; Benitez J; Zamora MP; Arias Perez JI; Anton-Culver H; Neuhausen SL; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Meindl A; Schmutzler RK; Brauch H; Ko YD; Brüning T; ; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Matsuo K; Ito H; Iwata H; Tanaka H; Dörk T; Bogdanova NV; Helbig S; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Lambrechts D; Zhao H; Weltens C; van Limbergen E; Chang-Claude J; Flesch-Janys D; Rudolph A; Seibold P; Radice P; Peterlongo P; Barile M; Capra F; Couch FJ; Olson JE; Hallberg E; Vachon C; Giles GG; Milne RL; McLean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; See MH; Cornes B; Cheng CY; Ikram MK; Kristensen V; ; Zheng W; Halverson SL; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Klevebring D; Darabi H; Eriksson M; Hooning MJ; Hollestelle A; Martens JW; Collée JM; Hall P; Li J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cox A; Cross SS; Reed MW; Blot W; Signorello LB; Cai Q; Shah M; Ghoussaini M; Kang D; Choi JY; Park SK; Noh DY; Hartman M; Miao H; Lim WY; Tang A; Hamann U; Torres D; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Olswold C; Slager S; Toland AE; Yannoukakos D; Shen CY; Wu PE; Yu JC; Hou MF; Swerdlow A; Ashworth A; Orr N; Jones M; Pita G; Alonso MR; Álvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Ahmed S; Healey CS; Brown MA; Ponder BA; Chenevix-Trench G; Thompson DJ; Edwards SL; Easton DF; Dunning AM; French JD
    Am J Hum Genet; 2015 Jan; 96(1):5-20. PubMed ID: 25529635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11q13 is a susceptibility locus for hormone receptor positive breast cancer.
    Lambrechts D; Truong T; Justenhoven C; Humphreys MK; Wang J; Hopper JL; Dite GS; Apicella C; Southey MC; Schmidt MK; Broeks A; Cornelissen S; van Hien R; Sawyer E; Tomlinson I; Kerin M; Miller N; Milne RL; Zamora MP; Pérez JI; Benítez J; Hamann U; Ko YD; Brüning T; ; Chang-Claude J; Eilber U; Hein R; Nickels S; Flesch-Janys D; Wang-Gohrke S; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Chenevix-Trench G; Beesley J; Chen X; ; ; Menegaux F; Cordina-Duverger E; Shen CY; Yu JC; Wu PE; Hou MF; Andrulis IL; Selander T; Glendon G; Mulligan AM; Anton-Culver H; Ziogas A; Muir KR; Lophatananon A; Rattanamongkongul S; Puttawibul P; Jones M; Orr N; Ashworth A; Swerdlow A; Severi G; Baglietto L; Giles G; Southey M; Marmé F; Schneeweiss A; Sohn C; Burwinkel B; Yesilyurt BT; Neven P; Paridaens R; Wildiers H; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Schott S; Bartram CR; Schmutzler RK; Cox A; Brock IW; Elliott G; Cross SS; Fasching PA; Schulz-Wendtland R; Ekici AB; Beckmann MW; Fletcher O; Johnson N; Silva Idos S; Peto J; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Dörk T; Schürmann P; Bremer M; Hillemanns P; Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Khusnutdinova E; Bermisheva M; Prokofieva D; Gancev S; Jakubowska A; Lubinski J; Jaworska K; Durda K; Nordestgaard BG; Bojesen SE; Lanng C; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Radice P; Peterlongo P; Manoukian S; Bernard L; Couch FJ; Olson JE; Wang X; Fredericksen Z; Alnaes GG; Kristensen V; Børresen-Dale AL; Devilee P; Tollenaar RA; Seynaeve CM; Hooning MJ; García-Closas M; Chanock SJ; Lissowska J; Sherman ME; Hall P; Liu J; Czene K; Kang D; Yoo KY; Noh DY; Lindblom A; Margolin S; Dunning AM; Pharoah PD; Easton DF; Guénel P; Brauch H
    Hum Mutat; 2012 Jul; 33(7):1123-32. PubMed ID: 22461340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews.
    Streicher SA; Klein AP; Olson SH; Amundadottir LT; DeWan AT; Zhao H; Risch HA
    Cancer Epidemiol Biomarkers Prev; 2017 Oct; 26(10):1540-1548. PubMed ID: 28754795
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study.
    Schmit SL; Schumacher FR; Edlund CK; Conti DV; Raskin L; Lejbkowicz F; Pinchev M; Rennert HS; Jenkins MA; Hopper JL; Buchanan DD; Lindor NM; Le Marchand L; Gallinger S; Haile RW; Newcomb PA; Huang SC; Rennert G; Casey G; Gruber SB
    Carcinogenesis; 2014 Nov; 35(11):2512-9. PubMed ID: 25023989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.
    Wyszynski A; Hong CC; Lam K; Michailidou K; Lytle C; Yao S; Zhang Y; Bolla MK; Wang Q; Dennis J; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Peto J; Dos-Santos-Silva I; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Nordestgaard BG; González-Neira A; Benitez J; Neuhausen SL; Brenner H; Dieffenbach AK; Meindl A; Schmutzler RK; Brauch H; ; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; ; Wu AH; Van Den Berg D; Lambrechts D; Wildiers H; Chang-Claude J; Rudolph A; Radice P; Peterlongo P; Couch FJ; Olson JE; Giles GG; Milne RL; Haiman CA; Henderson BE; Dumont M; Teo SH; Wong TY; Kristensen V; Zheng W; Long J; Winqvist R; Pylkäs K; Andrulis IL; Knight JA; Devilee P; Seynaeve C; García-Closas M; Figueroa J; Klevebring D; Czene K; Hooning MJ; van den Ouweland AM; Darabi H; Shu XO; Gao YT; Cox A; Blot W; Signorello LB; Shah M; Kang D; Choi JY; Hartman M; Miao H; Hamann U; Jakubowska A; Lubinski J; Sangrajrang S; McKay J; Toland AE; Yannoukakos D; Shen CY; Wu PE; Swerdlow A; Orr N; Simard J; Pharoah PD; Dunning AM; Chenevix-Trench G; Hall P; Bandera E; Amos C; Ambrosone C; Easton DF; Cole MD
    Hum Mol Genet; 2016 Sep; 25(17):3863-3876. PubMed ID: 27402876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.
    Baxter JS; Johnson N; Tomczyk K; Gillespie A; Maguire S; Brough R; Fachal L; Michailidou K; Bolla MK; Wang Q; Dennis J; Ahearn TU; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Augustinsson A; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bogdanova NV; Bojesen SE; Brenner H; Brucker SY; Cai Q; Campa D; Canzian F; Castelao JE; Chan TL; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Choi JY; Clarke CL; ; Colonna S; Conroy DM; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dossus L; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Engel C; Fasching PA; Figueroa J; Flyger H; Gago-Dominguez M; Gao C; García-Closas M; García-Sáenz JA; Ghoussaini M; Giles GG; Goldberg MS; González-Neira A; Guénel P; Gündert M; Haeberle L; Hahnen E; Haiman CA; Hall P; Hamann U; Hartman M; Hatse S; Hauke J; Hollestelle A; Hoppe R; Hopper JL; Hou MF; ; ; Ito H; Iwasaki M; Jager A; Jakubowska A; Janni W; John EM; Joseph V; Jung A; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kosma VM; Kraft P; Kristensen VN; Kubelka-Sabit K; Kurian AW; Kwong A; Lacey JV; Lambrechts D; Larson NL; Larsson SC; Le Marchand L; Lejbkowicz F; Li J; Long J; Lophatananon A; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Matsuo K; Mavroudis D; Mayes R; Menon U; Milne RL; Mohd Taib NA; Muir K; Muranen TA; Murphy RA; Nevanlinna H; O'Brien KM; Offit K; Olson JE; Olsson H; Park SK; Park-Simon TW; Patel AV; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Pylkäs K; Rack B; Rennert G; Romero A; Ruebner M; Rüdiger T; Saloustros E; Sandler DP; Sawyer EJ; Schmidt MK; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Shah M; Shen CY; Shu XO; Simard J; Southey MC; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Taylor JA; Teo SH; Teras LR; Terry MB; Toland AE; Tomlinson I; Truong T; Tseng CC; Untch M; Vachon CM; van den Ouweland AMW; Wang SS; Weinberg CR; Wendt C; Winham SJ; Winqvist R; Wolk A; Wu AH; Yamaji T; Zheng W; Ziogas A; Pharoah PDP; Dunning AM; Easton DF; Pettitt SJ; Lord CJ; Haider S; Orr N; Fletcher O
    Am J Hum Genet; 2021 Jul; 108(7):1190-1203. PubMed ID: 34146516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide Profiling Identifies DNA Methylation Signatures of Aging in Rod Photoreceptors Associated with Alterations in Energy Metabolism.
    Corso-Díaz X; Gentry J; Rebernick R; Jaeger C; Brooks MJ; van Asten F; Kooragayala K; Gieser L; Nellissery J; Covian R; Cogliati T; Mondal AK; Jiang K; Swaroop A
    Cell Rep; 2020 Apr; 31(3):107525. PubMed ID: 32320661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of multiple genetic variants with breast cancer susceptibility in the Han Chinese population.
    Li X; Zou W; Liu M; Cao W; Jiang Y; An G; Wang Y; Huang S; Zhao X
    Oncotarget; 2016 Dec; 7(51):85483-85491. PubMed ID: 27863437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in DNA repair pathways and risk of non-Hodgkin's lymphoma.
    Rendleman J; Antipin Y; Reva B; Adaniel C; Przybylo JA; Dutra-Clarke A; Hansen N; Heguy A; Huberman K; Borsu L; Paltiel O; Ben-Yehuda D; Brown JR; Freedman AS; Sander C; Zelenetz A; Klein RJ; Shao Y; Lacher M; Vijai J; Offit K; Kirchhoff T
    PLoS One; 2014; 9(7):e101685. PubMed ID: 25010664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder.
    Lencz T; Guha S; Liu C; Rosenfeld J; Mukherjee S; DeRosse P; John M; Cheng L; Zhang C; Badner JA; Ikeda M; Iwata N; Cichon S; Rietschel M; Nöthen MM; Cheng AT; Hodgkinson C; Yuan Q; Kane JM; Lee AT; Pisanté A; Gregersen PK; Pe'er I; Malhotra AK; Goldman D; Darvasi A
    Nat Commun; 2013; 4():2739. PubMed ID: 24253340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for tankyrases as antineoplastic targets in lung cancer.
    Busch AM; Johnson KC; Stan RV; Sanglikar A; Ahmed Y; Dmitrovsky E; Freemantle SJ
    BMC Cancer; 2013 Apr; 13():211. PubMed ID: 23621985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.
    Kirchhoff T; Gaudet MM; Antoniou AC; McGuffog L; Humphreys MK; Dunning AM; Bojesen SE; Nordestgaard BG; Flyger H; Kang D; Yoo KY; Noh DY; Ahn SH; Dork T; Schürmann P; Karstens JH; Hillemanns P; Couch FJ; Olson J; Vachon C; Wang X; Cox A; Brock I; Elliott G; Reed MW; Burwinkel B; Meindl A; Brauch H; Hamann U; Ko YD; ; Broeks A; Schmidt MK; Van 't Veer LJ; Braaf LM; Johnson N; Fletcher O; Gibson L; Peto J; Turnbull C; Seal S; Renwick A; Rahman N; Wu PE; Yu JC; Hsiung CN; Shen CY; Southey MC; Hopper JL; Hammet F; Van Dorpe T; Dieudonne AS; Hatse S; Lambrechts D; Andrulis IL; Bogdanova N; Antonenkova N; Rogov JI; Prokofieva D; Bermisheva M; Khusnutdinova E; van Asperen CJ; Tollenaar RA; Hooning MJ; Devilee P; Margolin S; Lindblom A; Milne RL; Arias JI; Zamora MP; Benítez J; Severi G; Baglietto L; Giles GG; ; ; Spurdle AB; Beesley J; Chen X; Holland H; Healey S; Wang-Gohrke S; Chang-Claude J; Mannermaa A; Kosma VM; Kauppinen J; Kataja V; Agnarsson BA; Caligo MA; Godwin AK; Nevanlinna H; Heikkinen T; Fredericksen Z; Lindor N; Nathanson KL; Domchek SM; ; Loman N; Karlsson P; Stenmark Askmalm M; Melin B; von Wachenfeldt A; ; Hogervorst FB; Verheus M; Rookus MA; Seynaeve C; Oldenburg RA; Ligtenberg MJ; Ausems MG; Aalfs CM; Gille HJ; Wijnen JT; Gómez García EB; ; Peock S; Cook M; Oliver CT; Frost D; Luccarini C; Pichert G; Davidson R; Chu C; Eccles D; Ong KR; Cook J; Douglas F; Hodgson S; Evans DG; Eeles R; Gold B; Pharoah PD; Offit K; Chenevix-Trench G; Easton DF;
    PLoS One; 2012; 7(6):e35706. PubMed ID: 22768030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polymorphism in the nuclear receptor coactivator 7 gene and breast cancer susceptibility.
    Süllner J; Lattrich C; Häring J; Görse R; Ortmann O; Treeck O
    Oncol Lett; 2012 Jan; 3(1):131-134. PubMed ID: 22740868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of genetic breast cancer susceptibility variants as prognostic factors.
    Fasching PA; Pharoah PD; Cox A; Nevanlinna H; Bojesen SE; Karn T; Broeks A; van Leeuwen FE; van't Veer LJ; Udo R; Dunning AM; Greco D; Aittomäki K; Blomqvist C; Shah M; Nordestgaard BG; Flyger H; Hopper JL; Southey MC; Apicella C; Garcia-Closas M; Sherman M; Lissowska J; Seynaeve C; Huijts PE; Tollenaar RA; Ziogas A; Ekici AB; Rauh C; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Andrulis IL; Ozcelik H; Mulligan AM; Glendon G; Hall P; Czene K; Liu J; Chang-Claude J; Wang-Gohrke S; Eilber U; Nickels S; Dörk T; Schiekel M; Bremer M; Park-Simon TW; Giles GG; Severi G; Baglietto L; Hooning MJ; Martens JW; Jager A; Kriege M; Lindblom A; Margolin S; Couch FJ; Stevens KN; Olson JE; Kosel M; Cross SS; Balasubramanian SP; Reed MW; Miron A; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Chenevix-Trench G; ; Lambrechts D; Dieudonne AS; Hatse S; van Limbergen E; Benitez J; Milne RL; Zamora MP; Pérez JI; Bonanni B; Peissel B; Loris B; Peterlongo P; Rajaraman P; Schonfeld SJ; Anton-Culver H; Devilee P; Beckmann MW; Slamon DJ; Phillips KA; Figueroa JD; Humphreys MK; Easton DF; Schmidt MK
    Hum Mol Genet; 2012 Sep; 21(17):3926-39. PubMed ID: 22532573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women.
    Dai J; Hu Z; Jiang Y; Shen H; Dong J; Ma H; Shen H
    Breast Cancer Res; 2012 Jan; 14(1):R17. PubMed ID: 22269215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage.
    Kang HC; Lee YI; Shin JH; Andrabi SA; Chi Z; Gagné JP; Lee Y; Ko HS; Lee BD; Poirier GG; Dawson VL; Dawson TM
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14103-8. PubMed ID: 21825151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling.
    Callow MG; Tran H; Phu L; Lau T; Lee J; Sandoval WN; Liu PS; Bheddah S; Tao J; Lill JR; Hongo JA; Davis D; Kirkpatrick DS; Polakis P; Costa M
    PLoS One; 2011; 6(7):e22595. PubMed ID: 21799911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multistage association study identifies a breast cancer genetic locus at NCOA7.
    Higginbotham KS; Breyer JP; Bradley KM; Schuyler PA; Plummer WD; Freudenthal ME; Trentham-Dietz A; Newcomb PA; Sanders ME; Page DL; Parl FF; Egan KM; Dupont WD; Smith JR
    Cancer Res; 2011 Jun; 71(11):3881-8. PubMed ID: 21610108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.